Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab®
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab®
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 5515-5527
Publisher
Informa UK Limited
Online
2020-06-12
DOI
10.2147/ott.s245169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Theranostic CAR T cell Targeting, a brief review
- (2019) Claudia Arndt et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Midostaurin abrogates CD 33‐directed Uni CAR and CD 33‐ CD 3 bispecific antibody therapy in acute myeloid leukaemia
- (2019) Frederick Fasslrinner et al. BRITISH JOURNAL OF HAEMATOLOGY
- The UniCAR system: A modular CAR T cell approach to improve the safety of CAR T cells
- (2019) Michael Bachmann IMMUNOLOGY LETTERS
- An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
- (2019) Justyna Jureczek et al. Scientific Reports
- T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
- (2019) Alexandra Kegler et al. OncoImmunology
- Conventional CARs versus modular CARs
- (2019) Anja Feldmann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
- (2018) Jang Hwan Cho et al. CELL
- Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology
- (2018) Stefanie Koristka et al. JOURNAL OF AUTOIMMUNITY
- Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
- (2018) Shivani Srivastava et al. JOURNAL OF IMMUNOLOGY
- Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
- (2018) Erhao Zhang et al. Molecular Cancer
- From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
- (2018) Susann Albert et al. Oncotarget
- Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy
- (2018) Jordan Gauthier et al. Current Research in Translational Medicine
- Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
- (2018) L. R. Loureiro et al. Blood Cancer Journal
- Emerging Cellular Therapies for Cancer
- (2018) Sonia Guedan et al. Annual Review of Immunology
- Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
- (2018) Jennifer N. Brudno et al. BLOOD REVIEWS
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
- (2018) Najat Bouchkouj et al. CLINICAL CANCER RESEARCH
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
- (2017) Dominik Bachmann et al. Oncotarget
- Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
- (2017) Nicola Mitwasi et al. Oncotarget
- Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
- (2017) Anja Feldmann et al. Oncotarget
- A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
- (2017) Susann Albert et al. OncoImmunology
- Versatile strategy for controlling the specificity and activity of engineered T cells
- (2016) Jennifer S. Y. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)
- (2016) Bahman Akbari et al. PROTEIN EXPRESSION AND PURIFICATION
- Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
- (2016) M Cartellieri et al. Blood Cancer Journal
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
- (2014) Katarzyna Urbanska et al. Journal of Translational Medicine
- Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B
- (2013) Stefanie Koristka et al. JOURNAL OF AUTOIMMUNITY
- Approval Summary: Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil for the First-Line Treatment of Patients With Recurrent Locoregional or Metastatic Squamous Cell Head and Neck Cancer
- (2013) M. H. Cohen et al. ONCOLOGIST
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding properties
- (2012) Michelle C. Vendel et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
- (2012) K. Tamada et al. CLINICAL CANCER RESEARCH
- Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
- (2011) Rodrigo Dienstmann et al. Molecular Oncology
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Retargeting of T cells to prostate stem cell antigen expressing tumor cells: Comparison of different antibody formats
- (2010) Anja Feldmann et al. PROSTATE
- Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment
- (2009) Jaume Capdevila et al. CANCER TREATMENT REVIEWS
- Pharmacological significance of glycosylation in therapeutic proteins
- (2009) Huijuan Li et al. CURRENT OPINION IN BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started